Avicenna Alliance: enhanced knowledge, improved decisions, better outcomes
FULL MENU

Pharmaceutical Strategy (Pharma) Task Force

Pharmaceutical Strategy (Pharma) Task Force

BACK

Pharmaceutical Strategy (Pharma) Task Force

Mission: Accelerate Adoption by Healthcare Stakeholders of In Silico Medicine for Bringing New Medicine to Patients

As the European Authorities are defining the evolution of their pharmaceutical strategies for the next few years, it is crucial to include new and critical technologies for the future. In silico technologies are, without any doubt, an essential tool that should be part of the pharmaceutical future of Europe.


The Pharma Strategy Task Force is acting as a Center of Expertise for In Silico approaches with representatives from Academia and Industry to inform and guide global Competent Authorities in this challenging task and propose concrete avenues, and texts, to engage Europe, US and other regions in the Digitalisation of the Regulatory Pharmaceutical activities”.

Goals

  • Address Regulatory Aspects of in silico medicine when used in Pharmaceuticals
  • Advocate use of in silico medicine for Pharmaceuticals for stakeholders
  • Increase confidence of Industry for use of in silico medicine for Pharmaceuticals
  • Identify use of in silico medicine for (specific) target indications and target populations

Yu Feng

Yu Feng

Co-Chair of the Pharmaceutical Strategy (Pharma) Task Force

Associate Professor Oklahoma State University

READ BIO

NEWS

News Avicenna at eHealth Stakeholders group meeting

Avicenna at eHealth Stakeholders group meeting

Very interesting exchanges yesterday, during the meeting of the e-health stakeholders group organized by the European Commission.

News Avicenna Alliance at University of Toulouse

Avicenna Alliance at University of Toulouse

On February 9, Noemie Dubruel, active member of the Avicenna Alliance as a doctoral student in Droit de la santé et de la recherche médicale at the University of Toulouse 1 Capitole and Thierry Marchal spoke at the Consortium Santé in silico 6 on synthetic data and simulation in the service of clinical research, organized by Nicolas Savy.

News Abimed is a new Avicenna Partner!

Abimed is a new Avicenna Partner!

We are delighted to welcome Abimed as a new Avicenna Partner.

Sign up for our monthly newsletter!

Sign up for our monthly newsletter!

Fill in the fields you find below

Avicenna Alliance is an initiative of:

Avicenna VPH

© 2018-2024 Avicenna Alliance | powered by We Berry